Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pozen Shares On The Rebound Since European Migraine Licensing Deal
Seeking Alpha
Monday, May 14, 2012 - 11:39am
tags:
Pozen, Europe, migraines, Desitin Arzneimittel GmbH, MT-400
Sales-needy Takeda springs for emerging markets growth
Fierce Pharma
Monday, May 14, 2012 - 11:37am
tags:
Takeda, emerging markets, M&A, Nycomed
Ventrus anal fissures cream meets goal; shares jump
Yahoo/AP
Monday, May 14, 2012 - 11:36am
tags:
Ventrus, anal fissure, VEN 307
Drug Approval! Oh, Wait, We Knew That Already.
Motley Fool
Monday, May 14, 2012 - 11:15am
tags:
drug approvals, Cell Therapeutics, Pixuvri, non-Hodgkin B-cell lymphoma, Europe
Mulling Arena Pharma's Future With Obesity Drug on Approval Path
TheStreet.com
Monday, May 14, 2012 - 11:14am
tags:
obesity, Arena Pharmaceuticals, FDA, lorcaserin
UK Pharma Trade Group May Restrict Samples
Pharmalot
Monday, May 14, 2012 - 11:12am
tags:
samples, UK, physicians
Prescribable Mobile Apps Huge Threat for Pharma
Forbes
Monday, May 14, 2012 - 10:38am
tags:
physicians, mobile apps
4 Big Pharma Stocks To Nab In A Pullback
Seeking Alpha
Monday, May 14, 2012 - 10:37am
tags:
Merck, Eli Lilly, Bristol-Myers Squibb, AstraZeneca
Teva Pharmaceuticals' Disappointing Results
Seeking Alpha
Monday, May 14, 2012 - 10:27am
tags:
Teva Pharmaceuticals, earnings
Loss Narrows at Auxilium
Yahoo/Zacks
Monday, May 14, 2012 - 10:22am
tags:
earnings, Auxilium
Myrexis Undervalued As BioPharma Transforms
Seeking Alpha
Monday, May 14, 2012 - 10:20am
tags:
Myrexis, JNJ, Abbott Laboratories, Pfizer
Why Johnson & Johnson Looks Better Than Its Competitors
Seeking Alpha
Monday, May 14, 2012 - 10:19am
tags:
JNJ, Human Genome Sciences, Pfizer, Sanofi, Edwards Lifesciences, GSK, AstraZeneca
Cancer Tools Help Roche Push Ahead With Alzheimer’s Drug
Bloomberg
Monday, May 14, 2012 - 10:17am
tags:
Roche, Alzheimer's disease, bapineuzumab
WuXi PharmaTech Earnings Call Insights: Backlog Recognition, Tox Business
Wall St. Cheat Sheet
Monday, May 14, 2012 - 10:14am
tags:
earnings, WuXi PharmaTech
6 Mid-Cap Biotechnology Stocks With Great Liquidity And Rated Buy Or Better
Seeking Alpha
Sunday, May 13, 2012 - 1:36pm
tags:
Seattle Genetics, Biomarin, Jazz Pharmaceuticals, Illumina, Questcor Pharmaceuticals, Vivus
Arena Pharmaceuticals: FDA Approval Is Just The Beginning
Seeking Alpha
Sunday, May 13, 2012 - 1:34pm
tags:
Arena Pharmaceuticals, lorcaserin, obesity, weight loss
Big Pharma Abandons Antibiotics: An Opening For Small Biotech
Seeking Alpha
Sunday, May 13, 2012 - 1:28pm
tags:
antibiotics
Teva CFO: The new CEO will bring changes
Globes, Israel
Sunday, May 13, 2012 - 1:27pm
tags:
Teva Pharmaceuticals
4 New Reasons To Be Bullish On Sanofi Now
Seeking Alpha
Sunday, May 13, 2012 - 1:26pm
tags:
Sanofi
5 Reasons To Buy Astex Pharmaceuticals
Seeking Alpha
Sunday, May 13, 2012 - 1:24pm
tags:
Astex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.